[Federal Register Volume 83, Number 220 (Wednesday, November 14, 2018)]
[Notices]
[Page 56800]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24797]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-70-2018]


Foreign-Trade Zone (FTZ) 52--Suffolk County, New York; 
Notification of Proposed Production Activity; LNK International, Inc. 
(Pharmaceutical Products), Hauppauge, New York

    Suffolk County, New York, grantee of FTZ 52, submitted a 
notification of proposed production activity to the FTZ Board on behalf 
of LNK International, Inc. (LNK), located at sites in Hauppauge, New 
York. The notification conforming to the requirements of the 
regulations of the FTZ Board (15 CFR 400.22) was received on November 
5, 2018.
    The LNK facilities are located within Subzone 52B. The facilities 
are used for the production of over-the-counter (OTC) analgesic 
pharmaceutical products. Pursuant to 15 CFR 400.14(b), FTZ activity 
would be limited to the specific foreign-status materials and 
components and specific finished products described in the submitted 
notification (as described below) and subsequently authorized by the 
FTZ Board.
    Production under FTZ procedures could exempt LNK from customs duty 
payments on the foreign-status components used in export production. On 
its domestic sales, for the foreign-status materials/components noted 
below, LNK would be able to choose the duty rates during customs entry 
procedures that apply to dosage form ibuprofen, aspirin and 
acetaminophen pharmaceutical products (duty-free). LNK would be able to 
avoid duty on foreign-status components which become scrap/waste. 
Customs duties also could possibly be deferred or reduced on foreign-
status production equipment.
    The components and materials sourced from abroad include: Ibuprofen 
active pharmaceutical ingredient; o-acetylsalicylic acid (aspirin) 
active pharmaceutical ingredient; diphenhydramine citrate; 
acetaminophen active pharmaceutical ingredient; caffeine; and, bulk 
mixture of acetaminophen (duty rates range from duty-free to 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary at the address 
below. The closing period for their receipt is December 24, 2018.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW, 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
Board's website, which is accessible via www.trade.gov/ftz.
    For further information, contact Diane Finver at 
[email protected] or (202) 482-1367.

    Dated: November 7, 2018.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2018-24797 Filed 11-13-18; 8:45 am]
 BILLING CODE 3510-DS-P